FDA approves new drug for menopausal hot flashes.

The FDA has approved a new once-a-day pill, Veozah, from Astellas Pharma to treat moderate-to-severe hot flashes caused by menopause. The drug uses a new approach, targeting brain connections that help control body temperature. More than 80% of women experience hot flashes during menopause, but the most common treatment, hormonal pills, isn't appropriate for some women. The new pill is not a hormone and carries an FDA warning about potential liver damage. It will cost $550 for a one-month supply before insurance coverage and other discounts.